C12N 5/0622
Glial cells
Official title: {Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells}
C12N5/0622 (Glial cells) appears on 318 US grants and 762 published applications in this corpus.
Search patents in C12N- Granted patents
- 318
- Published applications
- 762
- Assignees
- 382
- Inventors
- 1,376
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 2 |
| 2002 | 0 | 10 |
| 2003 | 2 | 16 |
| 2004 | 4 | 21 |
| 2005 | 4 | 29 |
| 2006 | 6 | 5 |
| 2007 | 7 | 15 |
| 2008 | 5 | 19 |
| 2009 | 8 | 22 |
| 2010 | 9 | 20 |
| 2011 | 7 | 15 |
| 2012 | 11 | 29 |
| 2013 | 8 | 15 |
| 2014 | 14 | 18 |
| 2015 | 16 | 23 |
| 2016 | 7 | 26 |
| 2017 | 13 | 34 |
| 2018 | 15 | 36 |
| 2019 | 23 | 57 |
| 2020 | 24 | 33 |
| 2021 | 18 | 39 |
| 2022 | 15 | 58 |
| 2023 | 14 | 61 |
| 2024 | 19 | 71 |
| 2025 | 18 | 47 |
| 2026 | 40 | 41 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Induced pluripotent stem cell derived glial enriched progenitor cells for the treatment of white matter stroke6 Oct 2026US 12,751,976 B2The Regents of the University of California
- Production method for microglia22 Sep 2026US 12,742,151 B2Elixirgen Scientific, Inc.
- Method for producing astrocyte-like cells15 Sep 2026US 12,735,677 B2Jsr Corporation
- Three-dimensional human neural tissues for CRISPR-mediated perturbation of disease genes15 Sep 2026US 12,736,526 B2Massachusetts Institutes of Technology
- Radial glia and astrocyte differentiation from human pluripotent stem cells8 Sep 2026US 12,729,367 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Universal treatment of down syndrome1 Oct 2026US 2026/0294978 A1DEI Biopharma
- Radial Glia and Astrocyte Differentiation from Human Pluripotent Stem Cells24 Sep 2026US 2026/0286296 A1The United States of America, as represented by the Secretary, Dept. of Heath and Human Services
- Generation of neurons by reprogramming of oligodendrocytes and oligodendrocyte precursor cells3 Sep 2026US 2026/0256853 A1The University of North Carolina at Chapel Hill
- Cell culture membrane structure, methods for producing the same, cell culture plate, cell culture apparatus comprising the cell culture membrane structure, and methods for cell cultivation by using the cell culture apparatus3 Sep 2026US 2026/0258340 A1Finnadvance Oy
- Microglia-sufficient brain organoids3 Sep 2026US 2026/0258354 A1Agency for Science, Technology and Research
Most cited
By later US patents
- Medium for growing human embryonic stem cells127US 7,297,539 B2Geron Corporation · 2007
- Culture system for rapid expansion of human embryonic stem cells97US 7,410,798 B2Geron Corporation · 2008
- Therapeutic uses for mesenchymal stromal cells86US 6,673,606 B1The Children’s Hospital of Philadelphia · 2004
- Isolated stromal cells for use in the treatment of diseases of the central nervous system65US 6,653,134 B2CP Hahnemann University · 2003
- Electroprocessed material made by simultaneously electroprocessing a natural protein polymer and two synthetic polymers60US 7,374,774 B2Virginia Commonwealth University Intellectual Property Foundation · 2008